International regulators and WHO call for wider public access to clinical data

7 May 2021 - The International Coalition of Medicines Regulatory Authorities and the World Health Organisation are urging pharmaceutical companies to ...

Read more →

FDA scraps another last-minute Trump-era policy

30 April 2021 - The US FDA on Friday revoked a policy issued in the final days of the Trump ...

Read more →

Prescription medicines: applications under evaluation

20 April 2021 - The TGA has updated its list of applications for new medicines or new uses for existing ...

Read more →

Department of Health publishes Public Summary Document for medicine without a published outcome

8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...

Read more →

More startling revelations from the Public Summary Document for upadacitinib monohydrate (Rinvoq)

8 March 2021 - Take a seat before reading any further. ...

Read more →

The future of drug pricing transparency

11 February 2021 - A federal “Transparency in Coverage” rule requires insurers to disclose list prices and historical net prices for ...

Read more →

EMA COVID-19 assessments ‘OPEN’ to non-EU regulators

4 February 2021 - EMA is piloting a new ‘OPEN’ initiative to increase international collaboration on the evaluation of COVID-19 vaccines ...

Read more →

Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding

2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient ...

Read more →

2021 April price disclosure cycle – indicative prices

20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...

Read more →

PHARMAC won’t release the data that changed its mind on diabetes

13 November 2020 - Diabetes Foundation Aotearoa will request the Ombudsman investigate the refusal by PHARMAC to release public submissions ...

Read more →

Extra transparency measures for COVID-19 vaccines and therapeutics

30 October 2020 - Today the EMA has implemented two further extra transparency measures for COVID-19 medicines, by publishing both ...

Read more →

Price transparency press call remarks by Administrator Seema Verma

29 October 2020 - Today’s price transparency announcement marks the culmination of four years of groundbreaking reforms.  ...

Read more →

White House to require insurers to post negotiated prices for medical care

29 October 2020 - Rule calls for gradually increasing disclosure requirements through 2024; health insurers say move could hurt competition, drive ...

Read more →

New transparency measures for prescription medicines

9 October 2020 - The Australian Government has given approval to proceed with two measures to enhance transparency for prescription ...

Read more →

FDA discloses vaccine guidelines blocked by White House

7 October 2020 - The FDA has laid out its safety standards for developers of COVID-19 vaccines after the White House ...

Read more →